Clal Biotechnology Industries Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
IL0011042806
Investment Holding Companies
Sales 2022 | 370K 99.87K 37M | Sales 2023 | 104K 28.07K 10.4M | Capitalization | 62.27M 16.81M 6.23B |
---|---|---|---|---|---|
Net income 2022 | -61M -16.46M -6.1B | Net income 2023 | -31M -8.37M -3.1B | EV / Sales 2022 | 331 x |
Net Debt 2022 | 23.85M 6.44M 2.38B | Net Debt 2023 | 22.4M 6.05M 2.24B | EV / Sales 2023 | 814 x |
P/E ratio 2022 |
-1.6
x | P/E ratio 2023 |
-2.01
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 34.65% |
Managers | Title | Age | Since |
---|---|---|---|
Assaf Segal
CEO | Chief Executive Officer | 51 | 15-06-30 |
Liat Nissan
DFI | Director of Finance/CFO | 46 | - |
Arnon Aharon
CTO | Chief Tech/Sci/R&D Officer | 55 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 03-05-08 | |
Yuval Yanai
BRD | Director/Board Member | 71 | 15-11-17 |
Gad Keren
BRD | Director/Board Member | 73 | 20-02-16 |
1st Jan change | Capi. | |
---|---|---|
+17.41% | 77.36B | |
+64.10% | 18.24B | |
+4.61% | 16.24B | |
+7.02% | 14.06B | |
-0.04% | 12.58B | |
+7.21% | 11.87B | |
+7.38% | 10.99B | |
+33.84% | 10.26B | |
+0.04% | 9.91B |